NVDB.US ProShares Ultra NVDA ETF
- Total assets
- 4.72M
- Expense ratio
- -
- Dividend yield
- 2.62%
- 1-year return
- -38.83%
- Holdings
- 1
- Since
- 2025
Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.
What does NVDB.US invest in?
- Mostly Cash (79.1%)
Asset allocation
- Cash 79.1%
- Other 36.3%
ProShares Ultra NVDA ETF performance
Sharpe ratio 0.00- This year
- -30.21%
- 1 year
- -38.83%
- 3 years
- -
- 5 years
- -
Volatility 58.4% over 1 year. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
NVDB.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About ProShares Ultra NVDA ETF
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. Under normal circumstances, the fund will invest at least 80% of the fund"s assets in, or provide exposure to, financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.
Full fund profileProShares Ultra NVDA ETF top holdings
The holdings of ProShares Ultra NVDA ETF are not available yet.
ProShares Ultra NVDA ETF fund profile
- Fund name
- ProShares Ultra NVDA ETF
- Ticker
- NVDB.US
- Exchange
- USA Stocks
- Issuer
- ProShares
- Index tracked
- -
- Category
- Leveraged & Inverse Equity
- Inception date
- Sep 8, 2025
- Trading currency
- USD
- Expense ratio
- -
About ProShares Ultra NVDA ETF
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. Under normal circumstances, the fund will invest at least 80% of the fund"s assets in, or provide exposure to, financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.